Sony Describes PSP As 'Gateway Drug'

We don't usually expect huge companies to compare their products to drugs in any way, but Sony is the kind of company that keeps us on our toes.

At the 6th annual Wedbush Morgan Securities Management Access Conference in New York City, SCEA senior marketing manager was quoted by GI.biz as described PSP as a "gateway drug" into the console world, describing consumers that buy the handheld moving on to purchase PS3 later on.

"It's become, from a gaming perspective, a lot different than I think we even envisioned it when we first launched it," he said.

"That's a very good thing. It's expansionary. For us, the PSP is a very high growth, high margin business and something that is a very good product for us."

"For us, it has been a really interesting experience. The PSP really parlays well into our broader hardware business," Koller added.